UnknownPHASE2, PHASE3NCT04081077

PRACTECAL-PKPD Sub Study

Studying Primary pulmonary tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medecins Sans Frontieres, Netherlands
Principal Investigator
Bern Nyang'wa, MB BS, MPH
Medecins Sans Frontieres, Netherlands
Intervention
Bedaquiline(drug)
Enrollment
240 target
Eligibility
18 years · All sexes
Timeline
2019 – 2022

Study locations (5)

Collaborators

London School of Hygiene and Tropical Medicine · Global Alliance for TB Drug Development · University College, London · Drugs for Neglected Diseases · Swiss Tropical & Public Health Institute · eResearch Technology, Inc. · Ministry of Health, Republic of Uzbekistan · World Health Organization · Ministry of Public Health, Republic of Belarus · THINK TB & HIV Investigative Network · University of Liverpool · Wits Health Consortium (Pty) Ltd · Hackensack Meridian Health · University of California, San Francisco · Minsk Republican Research and Practical Centre for Pulmonology and Tuberculosis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04081077 on ClinicalTrials.gov

Other trials for Primary pulmonary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary pulmonary tuberculosis →

← Back to all trials